<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20080901001174N14</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-05-28</date_registration>
      <primary_sponsor>Deputy of Research and Technology of Guilan University of Medical Sciences</primary_sponsor>
      <public_title>The effect of abdominal compression on consequences of cardiopulmonary resuscitation</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of abdominal compression on consequences of cardiopulmonary resuscitation in hospitalized patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-07-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/54584</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this research, block randomization based on block permutation will be used. Initially, based on the specified sample size, the samples will be placed inside the blocks and in each block there will be an equal number of control and intervention groups. The site https://www.sealedenvelope.com/, which was set up to randomize clinical trials, will be used to generate a random allocation sequence in each block. To hide the allocation, the block size will be selected randomly (4, 6). In this case, for the present study, which have two groups, blocks with a size of 4 will include 2 participants from the control group and 2 participants from the intervention group. Also, blocks with a size of 6 will include 3 participants from the control group and 3 participants from the intervention group. Sampling will continue based on the assigned sequences in each block to complete the specified sample size. If the patient leaves the study, the relevant code will be assigned to the next sample.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Cardiac arrest.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In the intervention group, chest compression will be performed 100 times in a minute at a depth of 5 cm and ventilation will be performed as soon as possible after intubation. Ventilation will be performed using an Ambobag and intravenous epinephrine and other drugs will be injected intravenously if necessary during resuscitation. Cardiopulmonary resuscitation will continue until the spontaneous return of blood flow and its termination will be one of the indications for termination of cardiopulmonary resuscitation. In this study, abdominal compression is performed simultaneously with chest compression with the hands open and integrated and it is applied in the center of the abdomen between the xiphoid process and the umbilicus during the resting phase of the chest compression. According to similar articles, the depth, rhythm and number of abdominal compression are similar to those of a chest compression, and the pressure on the abdomen continues until the next chest compression begins. Intervention 2: Control group: In this group, chest compression will be performed and ventilation will be performed as soon as possible after intubation. Ventilation will be performed using an Ambobag and intravenous epinephrine and other drugs will be injected intravenously if necessary during resuscitation. Cardiopulmonary resuscitation will continue until blood flow returns spontaneously and its termination will be one of the indications for termination of cardiopulmonary resuscitation.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Main and total data

When:
After publication of the results, the access period begins

To whom:
Universities and scientific institutions

Conditions:
In case of citing the article and observing the principles of intellectual property

Where to obtain:
Executor of proposal

How to obtain:
Contact with proposal executor and making ethical agreement

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Atefeh Ghanbari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing and Midwifery., Daneshjo St., shahid Beheshti highway.</address>
        <city>Rasht</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4146939841</zip>
        <telephone>+98 13 3355 5056</telephone>
        <email>at_ghanbari@gums.ac.ir</email>
        <affiliation>Guilan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Atefeh Ghanbari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing and Midwifery., Daneshjo St., shahid Beheshti highway.</address>
        <city>Rasht</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4146939841</zip>
        <telephone>+98 13 3355 5056</telephone>
        <email>at_ghanbari@gums.ac.ir</email>
        <affiliation>Guilan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Written informed consent from the client's family or guardian
Age of 18 to 85 years
Hospitalized patients with cardiopulmonary arrest</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>85 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients with liver cirrhosis
History of abdominal surgery in the last two weeks
Active gastrointestinal bleeding
Patients with abdominal ascites</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I46</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Cardiac arrest</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In the intervention group, chest compression will be performed 100 times in a minute at a depth of 5 cm and ventilation will be performed as soon as possible after intubation. Ventilation will be performed using an Ambobag and intravenous epinephrine and other drugs will be injected intravenously if necessary during resuscitation. Cardiopulmonary resuscitation will continue until the spontaneous return of blood flow and its termination will be one of the indications for termination of cardiopulmonary resuscitation. In this study, abdominal compression is performed simultaneously with chest compression with the hands open and integrated and it is applied in the center of the abdomen between the xiphoid process and the umbilicus during the resting phase of the chest compression. According to similar articles, the depth, rhythm and number of abdominal compression are similar to those of a chest compression, and the pressure on the abdomen continues until the next chest compression begins.</i_keyword>
      <i_keyword>Control group: In this group, chest compression will be performed and ventilation will be performed as soon as possible after intubation. Ventilation will be performed using an Ambobag and intravenous epinephrine and other drugs will be injected intravenously if necessary during resuscitation. Cardiopulmonary resuscitation will continue until blood flow returns spontaneously and its termination will be one of the indications for termination of cardiopulmonary resuscitation.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Spontaneous return of blood flow. Timepoint: After intervention (immediately after onset and half an hour after cardiopulmonary resuscitation). Method of measurement: Cardiopulmonary monitor.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Mean arterial pressure. Timepoint: After intervention (immediately after onset and half an hour after cardiopulmonary resuscitation). Method of measurement: Cardiopulmonary monitor.</sec_outcome>
      <sec_outcome>Arterial blood oxygen saturation. Timepoint: After intervention (immediately after onset and half an hour after cardiopulmonary resuscitation). Method of measurement: Arterial blood gas test.</sec_outcome>
      <sec_outcome>Heart rate. Timepoint: After intervention (immediately after onset and half an hour after cardiopulmonary resuscitation). Method of measurement: Cardiopulmonary monitor.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Deputy of Research and Technology of Guilan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-03-10</approval_date>
        <contact_name>Ethics Committee of Guilan University of Medical Sciences</contact_name>
        <contact_address>Deputy of Research and Technology of Guilan University of Medical Sciences., In front of 17Sharivar Hospital., Shahid Siadati St., Namjoo Blvd. Rasht Guilan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
